News
12 May 2026
Frost & Sullivan’s 2026 Global Company of the Year
Frost & Sullivan is pleased to announce that Avance Clinical has been awarded the 2026 Global Company of the Year Recognition in the biotechnology contract research organization (CRO) industry for its outstanding achievements in innovation, strategy execution, and customer impact.
11 January 2023
Avance Clinical Celebrates GlobalReady Success as More Than 40 Biotechs Enter Program
More than 40 biotech clients are now taking advantage of Avance Clinical’s GlobalReady program which delivers streamlined clinical development from early phase in Australia expanding to sites in North America for later phases.
12 December 2022
New Analyst Report – Avance Clinical GlobalReady for Biotechs
Frost & Sullivan applies a rigorous analytical process to evaluate multiple nominees for each award category before determining the final award recipient.
7 December 2022
Avance Clinical Wins Frost & Sullivan Customer Value Leadership Award 2022
After an extensive review by CRO industry analysts comprising executive interviews and background sector research, Frost & Sullivan has recognized Avance Clinical, the leading Australian-based biotech CRO with US operations, with the Frost & Sullivan’s 2022 Asia-Pacific Customer Value Leadership Award.
27 October 2022
Avance Clinical Sponsors China BioPharma Award at the Global Scrip Awards, London
Avance Clinical, the leading Australian-based biotech CRO with US operations will sponsor and present the China BioPharma Award at the global biotech Scrip Awards in London next month.
28 September 2022
Avance Clinical Wins International Health Award for Biotech CRO Services
Avance Clinical, the leading Australian-based biotech CRO with US operations has won the South Australian Premier’s Export Awards – International Health category. The award recognizes excellence in clinical services exports.
6 September 2022
Avance Clinical announces North American CRO acquisition to expand later phase services for Biotechs
Avance Clinical, the Australian CRO for biotechs, has expanded into North America with the acquisition of CRO partner company C3 Research Associates to enable biotech clients a seamless journey from early phase to later phase studies. Avance Clinical has backing from private equity group Riverside Company for their global expansion program.
24 August 2022
Avance Clinical Featured in Oracle Argus Capabilities Spotlight
Avance Clinical presented real world experience supporting biotech clinical trials using Oracle Argus. Hear from Avance Clinical’s Chief Scientific Officer Gabriel Kremmidiotis, and Drug Safety Manager Pilar Garzon.
24 August 2022
Avance Clinical MedTech Featured in Endpoints News – Most read article for the month
Innovative MedTech covers everything from physical devices, artificial intelligence (AI) and machine learning and digital healthcare, including biosensors in wearables like a watch, to a skin patch, or ingested or implanted devices.
9 June 2022
Avance Clinical Announces at BIO 2022: Expansion Across Australia and New Zealand – New Offices and Double Growth
Avance Clinical, the largest premium Australian Contract Research Organization (CRO) for international biotechs, has opened new offices in Sydney and Melbourne, with further expansions planned, and increased clinical staff numbers across the region to support double growth figures.
19 April 2022
Avance Clinical Finalist for Informa Pharma Intelligence Awards 2022 – Best Contract Research Organization in APAC
Avance Clinical, the largest premium Australian Contract Research Organization (CRO) for international biotechs, has been selected as a finalist for the Best Contract Research Organization in APAC by Informa Pharma Intelligence.
31 March 2022
Avance Clinical Announces New Office Opening in Melbourne
Avance Clinical, the Australian CRO for biotechs, has expanded into North America with the acquisition of CRO partner company C3 Research Associates to enable biotech clients a seamless journey from early phase to later phase studies. Avance Clinical has backing from private equity group Riverside Company for their global expansion program.
3 March 2022
Avance Clinical Announces Appointment of Liahna Toy as Head of Business Development
Avance Clinical, the largest full-service Australian Contract Research Organization (CRO) for international biotechs, announced today the appointment of Liahna Toy to the new senior executive role, Head of Business Development.
Proven industry
experience & expertise
500+
Studies in the past 5 years
450+
Experienced team members
18k+
Participants past 5 years
30
Years of CRO experience